eli lilly retatrutide phase 3 trial orforglipron oral GLP-1 weight loss Eli Lilly just announced striking
Description
Clinical Documentation: Ensures accurate and comprehensive clinical data (lab results, diagnostic codes, history) is captured and available for PA requests, identifying documentation gaps
Diarrhea affects 8-30%
p = 0.001), with one-third of patients achieving a clinically significant reduction of 4 points or more
This is the deal
A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Efficacy and Adverse Events
Hwang et al
